Clinical Trials
27 trialsNCT03722680 2026-05-20
RILUZOX-01
UNICANCER
Phase 2 Suspended
NCT06102902 2026-05-13
Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer
National Cancer Institute (NCI)
Phase 1 Suspended
NCT05200442 2026-05-08
A Study of VS-6766 and Cetuximab in Patients With Advanced Colorectal Cancer
University of Chicago
Phase 1/2 Suspended
NCT06653010 2026-05-07
Wondercel-UWD1
Wondercel Biotech (ShenZhen)
Phase EARLY_PHASE1 Suspended
NCT06675513 2026-05-07
Autologous CAR-T Cells (WD-01) for Metastatic Colorectal Cancer
Wondercel Biotech (ShenZhen)
Phase EARLY_PHASE1 Suspended
NCT07071961 2026-02-17
Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy [ReLOAD Trial]
M.D. Anderson Cancer Center
Phase 2 Suspended
NCT05241210 2025-12-09
Real-Time Feedback (RTFB) to Improve Colonoscopy
University of Minnesota
Phase NA Suspended
NCT04392050 2025-11-28
A Community-Based Educational Intervention to Improve Colorectal Cancer Screening
Thomas Jefferson University
Suspended
NCT05400122 2025-11-12
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
Case Comprehensive Cancer Center
Phase 1 Suspended
NCT04693546 2025-09-26
PREVENT
Metabiomics Corp
Suspended
NCT04031469 2025-07-31
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease
ProgenaBiome
Suspended
NCT05958199 2025-06-27
A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7
NextPoint Therapeutics, Inc.
Phase 1 Suspended
NCT05575765 2025-04-02
Clinical Validation of Multimodal Digestive Endoscopy
Xijing Hospital of Digestive Diseases
Suspended
NCT05375708 2025-03-28
SIRIUS
UMC Utrecht
Phase 2 Suspended
NCT04840186 2024-11-12
EXCALIBUR3
Oslo University Hospital
Phase 2 Suspended
NCT04714983 2024-04-09
DNX-2440 for Resectable Colorectal Liver Metastasis
DNAtrix, Inc.
Phase 1 Suspended
NCT03743428 2023-06-29
BABST-C
Shenzhen People's Hospital
Phase NA Suspended
NCT05506800 2023-02-23
Guangzhou Women's Health Cohort Study (GWHCS)
Guangzhou Women and Children's Medical Center
Suspended
NCT03970382 2022-08-18
A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors
PACT Pharma, Inc.
Phase 1 Suspended
NCT02121405 2022-05-11
PSSR
Zhejiang University
Phase 3 Suspended
NCT04985981 2021-12-01
The Prediction of Anastomotic Insufficiency Risk After Colorectal Surgery (PANIC) Study
Kantonsspital Winterthur KSW
Suspended
NCT03839277 2020-09-28
SinoEVADR
Changhai Hospital
Phase NA Suspended
NCT03253575 2019-04-08
ANCERS-2
Mitra RxDx, Inc.
Suspended
NCT01723306 2016-06-14
Phase II/Pilot Study of 2nd Generation Anti-CEA Designer T Cells in Adenocarcinomas
Roger Williams Medical Center
Phase 2 Suspended
NCT00609310 2012-02-03
Dietary Bioflavonoid Supplementation for the Prevention of Neoplasia Recurrence
Technische Universität Dresden
Phase 2 Suspended
NCT00443573 2008-05-07
Safety Study of Recombinant NAPc2 to Prevent Tumor Progression and Metastases in Metastatic Colon Cancer
ARCA Biopharma, Inc.
Phase 1/2 Suspended
NCT00316745 2007-11-01
IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer
Hokkaido Gastrointestinal Cancer Study Group
Phase 3 Suspended